VIREXX MEDICAL CORP has a total of 47 patent applications. Its first patent ever was published in 1999. It filed its patents most often in Canada, EPO (European Patent Office) and Israel. Its main competitors in its focus markets pharmaceuticals, biotechnology and medical technology are HEPACORE LTD, VACDIAGN BIOTECHNOLOGY CO LTD and AVM BIOTECHNOLOGY LLC.
# | Country | Total Patents | |
---|---|---|---|
#1 | Canada | 7 | |
#2 | EPO (European Patent Office) | 5 | |
#3 | Israel | 5 | |
#4 | United States | 5 | |
#5 | WIPO (World Intellectual Property Organization) | 5 | |
#6 | Republic of Korea | 3 | |
#7 | Taiwan | 3 | |
#8 | South Africa | 3 | |
#9 | Australia | 2 | |
#10 | Brazil | 2 | |
#11 | China | 2 | |
#12 | New Zealand | 2 | |
#13 | EAPO (Eurasian Patent Organization) | 1 | |
#14 | Mexico | 1 | |
#15 | Russian Federation | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Medical technology | |
#4 | Machines | |
#5 | Micro-structure and nano-technology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Peptides | |
#4 | Microorganisms | |
#5 | Object sterilising | |
#6 | Compounding processes | |
#7 | Preparation of materials | |
#8 | Medical purpose containers | |
#9 | Nanostructure applications |
# | Name | Total Patents |
---|---|---|
#1 | Noujaim Antoine | 24 |
#2 | Ma Allan | 16 |
#3 | Tyrrell Lorne | 15 |
#4 | George Rajan | 15 |
#5 | Stewart Michael W | 11 |
#6 | Wang Dakun | 10 |
#7 | Rajan George | 9 |
#8 | Motyka Bruce | 7 |
#9 | Person Roland H | 6 |
#10 | Noujaim Antoine A | 6 |
Publication | Filing date | Title |
---|---|---|
EP2198033A1 | Antigenic compositions and use of same in the targeted delivery of nucleic acids | |
CA2679792A1 | Methods for altering the shape of polymer particles | |
CA2623329A1 | Chimeric antigen containing hepatitis c virus polypeptide and fc fragment for eliciting an immune response | |
CA2556287A1 | Methods of treatment using vascular occlusion in combination with one or more therapies | |
CA2469087A1 | Compositions and methods for producing vascular occlusion | |
IL160799D0 | Vascular occlusion solid-phase agent with immobilised platelet binding agent | |
US6887474B1 | Compositions and methods for producing vascular occlusion |